Literature DB >> 25232475

Congenital Toxoplasmosis.

James B McAuley1.   

Abstract

Toxoplasmosis is caused by infection with the parasite Toxoplasma gondii. It is one of the most common parasitic infections in humans and is most typically asymptomatic. However, primary infection in a pregnant woman can cause severe and disabling disease in the developing fetus. Recent developments have included increased understanding of the role of parasite genotype in determining infectivity and disease severity. Risk factors for acquisition of infection have been better defined, and the important role of foodborne transmission has been further delineated. In addition, strategies have emerged to decrease mother-to-child transmission through prompt identification of acutely infected pregnant women followed by appropriate treatment. Refined diagnostic tools, particularly the addition of immunoglobulin G avidity testing, allow for more accurate timing of maternal infection and hence better decision making during pregnancy. Congenitally infected children can be treated, beginning in utero and continuing through the first year of life, to ameliorate the severity of disease. However, despite these many advances in our understanding of congenital toxoplasmosis prevention and treatment, significant areas of study remain: we need better drugs, well defined strategies for screening of pregnant women, improved food safety, and improved diagnostic tests.
© The Author 2014. Published by Oxford University Press on behalf of the Pediatric Infectious Diseases Society. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  infant; toxoplasmosis; transmission

Year:  2014        PMID: 25232475      PMCID: PMC4164182          DOI: 10.1093/jpids/piu077

Source DB:  PubMed          Journal:  J Pediatric Infect Dis Soc        ISSN: 2048-7193            Impact factor:   3.164


  20 in total

1.  Could Toxoplasma gondii have any role in Alzheimer disease?

Authors:  Ozge Yilmaz Kusbeci; Ozlem Miman; Mehmet Yaman; Orhan Cem Aktepe; Suleyman Yazar
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

2.  Tissue barriers of the human placenta to infection with Toxoplasma gondii.

Authors:  Jennifer R Robbins; Varvara B Zeldovich; Anna Poukchanski; John C Boothroyd; Anna I Bakardjiev
Journal:  Infect Immun       Date:  2011-11-14       Impact factor: 3.441

3.  Risk factors for Toxoplasma gondii infection in the United States.

Authors:  Jeffrey L Jones; Valerie Dargelas; Jacquelin Roberts; Cindy Press; Jack S Remington; Jose G Montoya
Journal:  Clin Infect Dis       Date:  2009-09-15       Impact factor: 9.079

4.  Value of prenatal diagnosis and early postnatal diagnosis of congenital toxoplasmosis: retrospective study of 110 cases.

Authors:  F Robert-Gangneux; M F Gavinet; T Ancelle; J Raymond; C Tourte-Schaefer; J Dupouy-Camet
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

5.  Annual burden of ocular toxoplasmosis in the US.

Authors:  Jeffrey L Jones; Gary N Holland
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

6.  Toxoplasma gondii seropositivity and suicide rates in women.

Authors:  Vinita J Ling; David Lester; Preben Bo Mortensen; Patricia W Langenberg; Teodor T Postolache
Journal:  J Nerv Ment Dis       Date:  2011-07       Impact factor: 2.254

7.  Risk factors for Toxoplasma gondii infection in mothers of infants with congenital toxoplasmosis: Implications for prenatal management and screening.

Authors:  Kenneth M Boyer; Ellen Holfels; Nancy Roizen; Charles Swisher; Douglas Mack; Jack Remington; Shawn Withers; Paul Meier; Rima McLeod
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

Review 8.  Central nervous system infections in immunocompromised patients: update on diagnostics and therapy.

Authors:  Martin Schmidt-Hieber; Janine Zweigner; Lutz Uharek; Igor W Blau; Eckhard Thiel
Journal:  Leuk Lymphoma       Date:  2009-01

9.  Maternal serologic screening to prevent congenital toxoplasmosis: a decision-analytic economic model.

Authors:  Eileen Stillwaggon; Christopher S Carrier; Mari Sautter; Rima McLeod
Journal:  PLoS Negl Trop Dis       Date:  2011-09-27

10.  Toxoplasma gondii oocyst-specific antibodies and source of infection.

Authors:  Claudia A Munoz-Zanzi; Paulina Fry; Blaz Lesina; Dolores Hill
Journal:  Emerg Infect Dis       Date:  2010-10       Impact factor: 6.883

View more
  47 in total

1.  Interpretation of the Elecsys Toxo IgG avidity results for very low and very high index: study on 741 sera with a determined date of toxoplasmosis.

Authors:  H Fricker-Hidalgo; C L'Ollivier; C Bosson; S Imbert; S Bailly; C Dard; R Piarroux; L Paris; H Pelloux
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-12-19       Impact factor: 3.267

2.  Evaluation of 4-Amino 2-Anilinoquinazolines against Plasmodium and Other Apicomplexan Parasites In Vitro and in a P. falciparum Humanized NOD-scid IL2Rγnull Mouse Model of Malaria.

Authors:  Paul R Gilson; William Nguyen; William A Poole; Jose E Teixeira; Jennifer K Thompson; Kaiyuan Guo; Rebecca J Stewart; Trent D Ashton; Karen L White; Laura M Sanz; Francisco-Javier Gamo; Susan A Charman; Sergio Wittlin; James Duffy; Christopher J Tonkin; Wai-Hong Tham; Brendan S Crabb; Brian M Cooke; Christopher D Huston; Alan F Cowman; Brad E Sleebs
Journal:  Antimicrob Agents Chemother       Date:  2019-02-26       Impact factor: 5.191

3.  Axillary lymphadenopathy in a pregnant woman: a case report.

Authors:  S Jalilzadeh Afshari; A Saad Abdalla Al-Zawi; P Idaewor; D W Chicken
Journal:  Ann R Coll Surg Engl       Date:  2020-04-29       Impact factor: 1.891

Review 4.  Altered Offspring Immunity in Maternal Parasitic Infections.

Authors:  Lisa C Gibbs; Keke C Fairfax
Journal:  J Immunol       Date:  2022-01-15       Impact factor: 5.422

Review 5.  Review of Experimental Compounds Demonstrating Anti-Toxoplasma Activity.

Authors:  Madalyn M McFarland; Sydney J Zach; Xiaofang Wang; Lakshmi-Prasad Potluri; Andrew J Neville; Jonathan L Vennerstrom; Paul H Davis
Journal:  Antimicrob Agents Chemother       Date:  2016-11-21       Impact factor: 5.191

Review 6.  Vaccines in Congenital Toxoplasmosis: Advances and Perspectives.

Authors:  Mariana Barros; Daniela Teixeira; Manuel Vilanova; Alexandra Correia; Natercia Teixeira; Margarida Borges
Journal:  Front Immunol       Date:  2021-02-15       Impact factor: 7.561

7.  Maternal toxoplasmosis and the risk of childhood autism: serological and molecular small-scale studies.

Authors:  Jamila S Al Malki; Nahed Ahmed Hussien; Fuad Al Malki
Journal:  BMC Pediatr       Date:  2021-03-17       Impact factor: 2.125

8.  Boromycin Has Potent Anti-Toxoplasma and Anti-Cryptosporidium Activity.

Authors:  Jaypee Abenoja; Alexis Cotto-Rosario; Roberta O'Connor
Journal:  Antimicrob Agents Chemother       Date:  2021-03-18       Impact factor: 5.938

9.  Prevalence of Toxoplasma gondii antibodies in domestic donkeys (Equus asinus) in Durango, Mexico slaughtered for human consumption.

Authors:  Cosme Alvarado-Esquivel; Domingo Alvarado-Esquivel; Jitender P Dubey
Journal:  BMC Vet Res       Date:  2015-01-17       Impact factor: 2.741

Review 10.  The pathogenesis of microcephaly resulting from congenital infections: why is my baby's head so small?

Authors:  L D Frenkel; F Gomez; F Sabahi
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-10-05       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.